北京热景生物技术股份有限公司关于公司及子公司近期获得资质情况的自愿披露公告

Group 1 - The company and its subsidiaries have recently obtained 25 overseas certifications and 2 authorized patents, enhancing its product offerings and intellectual property protection [1] - The acquisition of these qualifications responds to overseas market demands, improving the company's market expansion capabilities and core competitiveness [1] Group 2 - The company will continue to increase investment in product research and development, aiming to launch products that significantly contribute to human health and life [2]